Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase

Vaccine

Volumn 22, Issue 17-18, 2004, Pages 2137-2145

  Stewart Tull, Duncan E S ^a   Lucas, Carol ^a,b   Bleakley, Carol R ^a,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c BRITISH STANDARDS INSTITUTION   (United Kingdom)

Author keywords

Cholera; Mucinases; Vaccine; Vibrio cholerae

Indexed keywords

ACELLULAR VACCINE; ALUMINUM HYDROXIDE; CHOLERA TOXIN; CHOLERA VACCINE; CIMETIDINE; HYALURONIDASE; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; PROTEINASE; SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIUM ADHERENCE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; GRAM NEGATIVE INFECTION; GUINEA PIG; ILEUM; IMMUNE RESPONSE; INFECTION PREVENTION; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; STOMACH PH; VACCINATION; VIBRIO CHOLERAE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ALUMINUM HYDROXIDE; ANIMALS; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; FREUND'S ADJUVANT; GUINEA PIGS; ILEUM; INJECTIONS, INTRAMUSCULAR; NEURAMINIDASE; PEPTIDE HYDROLASES; POLYSACCHARIDE-LYASES; TOXOIDS; VACCINATION; VACCINES, INACTIVATED; VACCINES, SUBUNIT; VIBRIO CHOLERAE;

EID: 2442431542     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.12.004     Document Type: Article

References (56)

1. Mäkelä P.H. Vaccines, coming of age after 200 years. FEMS Microbiol. Rev. 26:2000;9-20
2. Travis J., Potempa J., Maeda H. Are bacterial proteinases pathogenic factors? Trends Microbiol. 3:1995;405-407
3. Stewart-Tull D.E.S., Ollar R.A., Scobie T.S. Studies on the Vibrio cholerae mucinase complex. I. Enzymic activities associated with the complex. J. Med. Microbiol. 22:1986;325-333
4. Ollar R.A., Stewart-Tull D.E.S. Studies on the Vibrio cholerae mucinase complex. II. Specific neuraminidase activity measured histochemically in a goblet cell assay. J. Med. Microbiol. 23:1987;227-232
5. Stewart-Tull D.E.S., Ollar R.A. Studies on the Vibrio cholerae mucinase complex. III. Neutralisation of the neuraminidase activity by specific anti-neuraminidase IgG. J. Med. Microbiol. 25:1988;123-128
6. Dutta N.K., Panse M.V., Kulkarni D.R. Role of cholera toxin in experimental cholera. J. Bact. 78:1959;594-595
7. De S.N., Ghose M.L., Sen A. Activities of bacteria-free preparations from Vibrio cholerae. J. Path. Bact. 79:1960;373-380
8. Pitkin D., Actor P. Immunity to Vibrio cholerae in the mouse. I. Passive protection of newborn mice. Infect. Immun. 5:1972;428-432
9. Leitch G.J., Burrows W. Experimental cholera in the rabbit ligated intestine: ion and water accumulation in the duodenum, ileum and colon. J. Infect. Dis. 118:1968;349-359
10. Carpenter C.C.J., Sack R.B., Feeley J.C., Steenberg R.W. Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J. Clin. Invest. 47:1968;1210-1220
11. Aziz K.M.S., Mohsin A.K.M., Hare W.K., Phillips R.A. Using the rat as a cholera "model" Nature. 220:1968;814-815
12. Basu S., Picket M.J. Reaction of Vibrio cholerae and choleragenic toxin in ileal loops of laboratory animals. J. Bact. 100:1969;1142-1143
13. Kasai G.J., Burrows W. The titration of cholera toxin and anti-toxin in the rabbit ileal loop. J. Infect. Dis. 116:1966;606-614
14. Peterson J.W., LoSpalluto J.J., Finkelstein R.A. Localization of cholera toxin in vivo. J. Infect. Dis. 126:1972;617-628
15. Walker W.A., Field M., Isselbacher K.J. Specific binding of cholera toxin to isolated intestinal microvillous membranes. Proc. Natl. Acad. Sci. U.S.A. 71:1974;320-324
16. Mosley W.H., Ahmed A. Active and passive immunisation in the adult rabbit ileal loop model as an assay for production of anti-toxin immunity by cholera vaccines. J. Bact. 100:1969;547-549
17. Nelson E.T., Clements J.D., Finkelstein R.A. Vibrio cholerae adherence and colonization in experimental cholera: electron microscopic studies. Infect. Immun. 14:1976;527-547
18. Sedmark J.J., Grossberg S.E. Comparative enzyme kinetics of influenza neuraminidase with the synthetic substrate methoxyphenyl-neuraminic acid. Virology. 56:1973;658-661
19. Lin Y., Means G.E., Feeney R.E. The action of proteolytic enzymes on N, N-dimethyl proteins. J. Biol Chem. 244:1969;789-793
20. Stewart-Tull DES, Bleakley CR, Galloway TS. Characteristics of Vibrio cholerae proteinase: potential, candidate vaccine antigens. Vaccine 2004; doi:10.1016/j.vaccine.2004.02.012.
21. Craig J.P. Preparation of the vascular permeability factor of Vibrio cholerae. J. Bact. 92:1966;793-795
22. Hughes M., Thomson R.O., Knight P. The immunopurification of tetanus toxoid. J. Appl. Bact. 37:1974;603-621
23. Stewart-Tull D.E.S., Shimono T., Kotani S., Kato M., Ogawa Y., Yamamura Y., et al. The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT. Immunology. 29:1975;1-15
24. Wardlaw AC. Practical statistics for experimental biologists. 2nd ed. Chichester: Wiley; 2000.
25. Herbert WJ. Passive haemagglutination. In: Weir DM, editor. Handbook of experimental immunology. Oxford: Blackwell Scientific Publications; 1967. p. 720-744 [chapter 21].
26. Craig J.P. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralisation by convalescent cholera sera. Nature. 207:1965;14-16
27. Finkelstein R.A. Cholera. Crit. Rev. Microbiol. 2:1973;553-623
28. Kaper J.B., Morris J.G. Jr., Levine M.M. Cholera. Crit. Rev. Microbiol. 8:1995;48-86
29. Richie E.E., Punjabi N.H., Sidharta Y.Y. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine. 18:2000;2399-2410
30. Dougan G., Huett A., Clare S. Vaccines against human enteric bacterial pathogens. Br. Med. Bull. 62:2002;113-123
31. Stewart-Tull D.E.S., Jones A.C. Adjuvants should not induce allergic reactions to protein antigens. FEMS Lett. 100:1992;489-496
32. Mekalanos J.J., Rubin E.J., Waldor M.K. Cholera: molecular basis for emergence and pathogenesis. FEMS Immunol. Med. Microbiol. 18:1997;241-248
33. Stewart-Tull D.E.S. Vaba, haiza, kholera, foklune or cholera: in any language still the disease of seven pandemics. J. Appl. Microbiol. 91:2001;580-591
34. Spangler B.D. Structure and function of cholera toxin and related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:1992;622-647
35. Levine M.M., Kaper J.B., Herrington D., Losonsky G., Tall B., Kaper J.B., et al. Safety, immunogenicity and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet. ii:1988;467-470
36. Levine M.M., Kaper J.B. Live oral vaccines against cholera: an update. Vaccine. 11:1993;207-212
37. Levine M.M., Kaper J.B., Herrington D., Losonsky G., Morris J.G., Clements M.L., et al. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect. Immun. 56:1988;161-167
38. Finkelstein R.A. Immunology of cholera. Curr. Top. Microbiol. Immunol. 69:1975;137-195
39. Pierce N.F., Kaniecki E.A., Northrup R.S. Protection against experimental cholera by anti-toxin. J. Infect. Dis. 126:1972;606-616
40. Levine M.M., Nalin D.R., Craig J.P., Hoover D., Berequist E.J., Waterman D., et al. Immunity of cholera in man: relative role of antibacterial versus anti-toxic immunity. Trans. R. Soc. Trop. Med. Hyg. 73:1979;3-9
41. Boyd T.E. Influence of alkalies on secretion and composition of gastric juice, effect of prolonged administration of sodium bicarbonate and calcium carbonate. Am. J. Physiol. 71:1925;455-463
42. Farrell J.I. Contributions to physiology of gastric secretion; response of glands to substances applied to gastric mucosa. Am. J. Physiol. 85:1928;672-684
43. Kozlowski P.A., Williams S.B., Lynch R.M., Flanigan T.P., Patterson R.R., Cu-Uvin S., et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal or vaginal immunisation: influence of the menstrual cycle. J. Immunol. 169:2002;566-574
44. Van Ginkel F.W., Jackson R.J., Yuki Y., McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165:2000;4778-4782
45. Hagiwara Y., Iwasaki T., Asanuma H., Sato Y., Sata T., Aizawa C., et al. Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile toxin) B subunits supplemented with a trace amount of the holotoxin on the brain. Vaccine. 19:2000;1652-1660
46. Stewart-Tull DES. Recommendations for the assessment of adjuvants (immunopotentiators). In: Gregoriadis G, Allison AC, Poste G, editors. Immunological adjuvants and vaccines. Nato ASI Series A: Life Sciences, vol. 179. New York: Plenum Press; 1989. p. 213-26.
47. Northrup R.S., Fauci A.S. Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells. J. Infect. Dis. 125:1972;672-673
48. Lycke N., Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology. 59:1986;301-308
49. Lycke N., Strober W. Cholera toxin promotes B cell isotype differentiation. J. Immunol. 142:1989;3781-3787
50. Bromander A., Holmgren J., Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:1991;2908-2914
51. Lycke N., Karlsson A., Sjölander A., Magnusson K.-E. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol. 33:1991;691-698
52. McGhee J.R., Mestecky J., Dertzbaugh M.T. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:1992;75-88
53. Stewart-Tull DES. Adjuvant formulations for experimental vaccines. In: Robinson A, Hudson MJ, Cranage MP. Vaccine protocols. 2nd ed. Totowa, NJ: Humana Press; 2003. p. 175-93.
54. Lencer W.I., Constable C., Moe S., Jobling M.G., Webb H.M., Ruston S., et al. Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL. J. Cell Biol. 131:1995;951-962
55. Svennerholm A.-M., Holmgren J. Synergistic protective effect in rabbits of immunisation with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect. Immun. 13:1976;735-740
56. Levine M., Kaper J.B., Black R.E., Clements M.L. New knowledge on the pathogenesis of bacterial enteric infections as applied to vaccine development. Micro. Rev. 47:1983;510-550